Acadia Healthcare (NASDAQ:ACHC) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Acadia Healthcare (NASDAQ:ACHC – Get Rating) in a research report issued on Thursday. The firm set a “hold” rating on the stock.

Several other analysts have also recently commented on the stock. Royal Bank of Canada decreased their price target on shares of Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating on the stock in a research note on Monday, December 12th. Loop Capital raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the company from $90.00 to $95.00 in a research note on Monday, December 12th. Stephens decreased their price target on shares of Acadia Healthcare from $92.00 to $88.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 1st. Mizuho cut their price objective on shares of Acadia Healthcare from $87.00 to $80.00 and set a “neutral” rating on the stock in a report on Monday, March 6th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Acadia Healthcare from $82.00 to $75.00 and set a “hold” rating on the stock in a report on Monday, March 6th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Acadia Healthcare has an average rating of “Moderate Buy” and an average price target of $89.67.

Acadia Healthcare Price Performance

ACHC opened at $68.46 on Thursday. Acadia Healthcare has a one year low of $63.20 and a one year high of $89.85. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.30 and a quick ratio of 1.30. The company’s 50 day simple moving average is $80.09 and its 200-day simple moving average is $81.48. The stock has a market capitalization of $6.25 billion, a P/E ratio of 22.82, a price-to-earnings-growth ratio of 1.47 and a beta of 1.31.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently bought and sold shares of ACHC. Durable Capital Partners LP raised its holdings in Acadia Healthcare by 164.6% in the third quarter. Durable Capital Partners LP now owns 1,483,908 shares of the company’s stock worth $116,012,000 after purchasing an additional 923,067 shares during the period. Point72 Asset Management L.P. raised its holdings in Acadia Healthcare by 543.1% in the second quarter. Point72 Asset Management L.P. now owns 612,988 shares of the company’s stock worth $41,456,000 after purchasing an additional 517,669 shares during the period. Alyeska Investment Group L.P. bought a new stake in shares of Acadia Healthcare during the first quarter worth $28,751,000. Fred Alger Management LLC increased its position in shares of Acadia Healthcare by 17.3% during the third quarter. Fred Alger Management LLC now owns 2,026,516 shares of the company’s stock worth $158,433,000 after acquiring an additional 298,324 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of Acadia Healthcare by 75.5% during the second quarter. Principal Financial Group Inc. now owns 536,567 shares of the company’s stock worth $36,288,000 after acquiring an additional 230,874 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors and hedge funds.

Acadia Healthcare Company Profile

(Get Rating)

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services.